Commission Regulation (EC) No 2229/2004 of 3 December 2004 laying down further detailed rules for the implementation of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC (Text with EEA relevance) (revoked)
EU Regulation No 2229/2004 · Adopted 3 December 2004 · Extends to United Kingdom
Commission Regulation (EC) No 2229/2004
of 3 December 2004
laying down further detailed rules for the implementation of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC
(Text with EEA relevance) (revoked)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
- F1
Regulation revoked (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), reg. 1(1), Sch. 2 Pt. 1 (with reg. 29(2)) (as amended by S.I. 2020/1376, regs. 1(4), 3(20)); 2020 c. 1, Sch. 5 para. 1(1)
Contents
- Chapter I: SUBJECT MATTER AND SCOPE, DEFINITIONS AND THE DESIGNATED MEMBER STATE AUTHORITY Repealed
- 1Subject matter and scope Repealed
- 2Definitions Repealed
- 3Designated Member State authority Repealed
- Chapter II: NOTIFICATIONS BY PRODUCERS IN NEW MEMBER STATES OF ACTIVE SUBSTANCES Repealed
- 4Notifications by producers in new Member States Repealed
- Chapter III: CONDITIONS FOR THE SUBMISSION OF DOSSIERS OF ACTIVE SUBSTANCES AND SUBMISSION OF INFORMATION BY THIRD PARTIES Repealed
- 5Submission of dossiers by more than one notifier Repealed
- 6Submission of dossiers to the rapporteur Member State Repealed
- 7Dossiers for active substances submitted under Directive 98/8/EC Repealed
- 8Dossiers for active substances submitted under Regulation (EC) No 1490/2002 Repealed
- 9Specific conditions for submissions of dossiers for active substances listed in Part A of Annex I Repealed
- 10Specific conditions for submissions of dossiers for active substances listed in Parts B to G of Annex I Repealed
- 11Submission of information by third parties Repealed
- 12Time limits for submission of dossiers Repealed
- 13Non-submission of dossiers Repealed
- 14Replacement or withdrawal of notifier Repealed
- Chapter IV: EVALUATIONS OF DOSSIERS Repealed
- 15General Conditions for evaluations of dossiers Repealed
- 16Cooperation between Member States Repealed
- 17Specific condition for evaluations of active substances listed in Part A of Annex I Repealed
- 18Completeness check of dossiers for substances listed in Parts B to G of Annex I Repealed
- 19Specific conditions for evaluations of dossiers for substances listed in Parts B to G of Annex I Repealed
- 20General conditions for draft Assessment Reports Repealed
- 21Specific conditions for draft Assessment Reports and Recommendations to the Commission for active substances listed in Part A of Annex I Repealed
- 22Specific conditions for draft Assessment Reports and Recommendations to the Commission for active substances listed in Parts B to G of Annex I Repealed
- 23Replacement of rapporteur Member State Repealed
- 24Receipt of and access to the draft assessment report Repealed
- 24aEvaluation of the draft assessment report Repealed
- 24bActive substances with clear indications that they do not have any harmful effects Repealed
- 24cConsultation of the EFSA Repealed
- 24dSubmission of additional information after the draft assessment report has been submitted to the EFSA Repealed
- 24eWithdrawal by notifier Repealed
- 24fActive substance for which there are clear indications of harmful effects Repealed
- Chapter V: PRESENTATION OF A DRAFT DIRECTIVE OR DRAFT DECISION CONCERNING ACTIVE SUBSTANCES AND FINALISED REVIEW REPORT Repealed
- 25Presentation of a draft directive or draft decision Repealed
- 25aView by the EFSA Repealed
- 26Finalised review report Repealed
- Chapter VI: SUSPENSION OF TIME LIMITS, MEASURES TO BE TAKEN BY MEMBER STATES AND INTERIM PROGRESS REPORTS Repealed
- 27Suspension of time limits Repealed
- 28Measures taken by Member States Repealed
- 29Interim progress report Repealed
- Chapter VII: FEES AND OTHER CHARGES Repealed
- 30Fees Repealed
- 31Other charges, taxes, levies or fees Repealed
- Chapter VIII: TEMPORARY AND FINAL PROVISIONS Repealed
- 32Temporary measures Repealed
- 33Entry into force Repealed
- Signature
- Annex I: List of active substances (column A), rapporteur Member States (column B) and notifying producers (code identification) (column C) Repealed
- PART ADivision PART A Repealed
- GROUP 1 Repealed
- GROUP 2 Repealed
- Group 2.1. Repealed
- Group 2.2. Repealed
- GROUP 3 Repealed
- GROUP 4 Repealed
- GROUP 5 Repealed
- GROUP 6 Repealed
- Group 6.1. Repealed
- Group 6.2. Repealed
- PART BDivision PART B Repealed
- PART CDivision PART C Repealed
- PART DDivision PART D Repealed
- PART EDivision PART E Repealed
- PART FDivision PART F Repealed
- PART GDivision PART G Repealed
- Annex IIAnnex II Repealed
- Annex IIICo-ordinating authority in the Member States (more details are available at the following webside: http://www.europa.eu.int/comm/food/fs/ph_ps/pro/index_en.htm) Repealed
- Annex IVOrganisations in the Member States to be contacted concerning further details on the payment of the fees referred to in Article 30 and to which such fees have to be paid Repealed
- Annex VDetails to be notified by producers in new Member States Repealed
- Annex VICriteria for clear indications of no harmful effects Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- Annex VIICriteria for clear indications of harmful effects Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
1Subject matter and scopeF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2DefinitionsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Designated Member State authorityF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Notifications by producers in new Member StatesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Submission of dossiers by more than one notifierF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6Submission of dossiers to the rapporteur Member StateF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7Dossiers for active substances submitted under Directive 98/8/ECF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Dossiers for active substances submitted under Regulation (EC) No 1490/2002F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9Specific conditions for submissions of dossiers for active substances listed in Part A of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Specific conditions for submissions of dossiers for active substances listed in Parts B to G of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11Submission of information by third partiesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12Time limits for submission of dossiersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13Non-submission of dossiersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14Replacement or withdrawal of notifierF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15General Conditions for evaluations of dossiersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16Cooperation between Member StatesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17Specific condition for evaluations of active substances listed in Part A of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18Completeness check of dossiers for substances listed in Parts B to G of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19Specific conditions for evaluations of dossiers for substances listed in Parts B to G of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20General conditions for draft Assessment ReportsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21Specific conditions for draft Assessment Reports and Recommendations to the Commission for active substances listed in Part A of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22Specific conditions for draft Assessment Reports and Recommendations to the Commission for active substances listed in Parts B to G of Annex IF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
23Replacement of rapporteur Member StateF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24Receipt of and access to the draft assessment reportF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24aEvaluation of the draft assessment reportF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24bActive substances with clear indications that they do not have any harmful effectsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24cConsultation of the EFSAF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24dSubmission of additional information after the draft assessment report has been submitted to the EFSAF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24eWithdrawal by notifierF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24fActive substance for which there are clear indications of harmful effectsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25Presentation of a draft directive or draft decisionF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25aView by the EFSAF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26Finalised review reportF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27Suspension of time limitsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
28Measures taken by Member StatesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29Interim progress reportF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30FeesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31Other charges, taxes, levies or feesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
32Temporary measuresF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
33Entry into forceF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Signature
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART AF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Group 2.1.F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Group 2.2.F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 5F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GROUP 6F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Group 6.1.F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Group 6.2.F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART BF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART CF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART DF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART EF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART FF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART GF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex IIF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex IIICo-ordinating authority in the Member States (more details are available at the following webside: http://www.europa.eu.int/comm/food/fs/ph_ps/pro/index_en.htm)F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex IVOrganisations in the Member States to be contacted concerning further details on the payment of the fees referred to in Article 30 and to which such fees have to be paidF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex VDetails to be notified by producers in new Member StatesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex VICriteria for clear indications of no harmful effectsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex VIICriteria for clear indications of harmful effectsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .